Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3597
+0.02146.33%
Pre-market: 0.38390.0242+6.73%08:00 EDT
Volume:816.51K
Turnover:279.58K
Market Cap:57.58M
PE:-0.44
High:0.3741
Open:0.3383
Low:0.3045
Close:0.3383
Loading ...
Oct 28, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Oct 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 16, 2024

Major Issues Report

Form 8-K - Current report
Oct 10, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 01, 2024

Correspondence

Form CORRESP - Correspondence
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 11, 2024

Major Issues Report

Form 8-K - Current report
Aug 20, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 20, 2024

Major Issues Report

Form 8-K - Current report
Aug 16, 2024

Correspondence

Form CORRESP - Correspondence
Jul 03, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2024

Correspondence

Form CORRESP - Correspondence
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 16, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]